Neuren Pharmaceuticals (NURPF) Stock Chart & Stock Price History C$8.45 0.00 (0.00%) (As of 11/7/2024 ET) Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort Interest Neuren Pharmaceuticals Stock Price Performance5 Day Performance-5.80%1 Month Performance-10.11%3 Month PerformanceN/A6 Month PerformanceN/AYear-To-Date Performance-50.24%1 Year Performance+3.11% Receive NURPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neuren Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide NURPF Stock Chart for Friday, November, 8, 2024 NURPF Chart by TradingView Neuren Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/06/2024C$8.45C$8.45C$8.45C$8.45222 shsC$0.0011/05/2024C$8.97C$8.45-5.80%C$8.45C$8.45222 shsC$0.0011/04/2024C$8.97C$8.97C$9.95C$8.97200 shsC$0.0011/01/2024C$8.15C$8.97+10.06%C$9.95C$8.97200 shsC$0.0010/31/2024C$8.81C$8.15-7.49%C$8.15C$8.15127 shsC$0.0010/28/2024C$8.81C$8.81C$9.00C$8.813,100 shsC$0.00 Get the Latest News and Ratings for NURPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neuren Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024C$6.83C$8.81+28.99%C$9.00C$8.813,100 shsC$0.0010/24/2024C$6.83C$6.83C$6.83C$6.83100 shsC$0.0010/17/2024C$6.83C$6.83C$6.83C$6.83100 shsC$0.0010/16/2024C$6.61C$6.83+3.33%C$6.83C$6.83100 shsC$0.0010/14/2024C$6.61C$6.61C$8.65C$6.613,800 shsC$0.0010/11/2024C$9.02C$6.61-26.72%C$8.65C$6.613,800 shsC$0.0010/10/2024C$9.02C$9.02C$9.02C$9.02250 shsC$0.0010/09/2024C$9.40C$9.02-4.04%C$9.02C$9.02250 shsC$0.0010/08/2024C$10.33C$9.40-9.00%C$9.40C$9.40150 shsC$0.0010/01/2024C$10.33C$10.33C$10.33C$10.3310 shsC$0.0009/30/2024C$10.33C$10.33C$10.33C$10.33100 shsC$0.0009/27/2024C$9.36C$10.33+10.36%C$10.33C$10.33100 shsC$0.0009/26/2024C$9.61C$9.36-2.60%C$9.36C$9.36350 shsC$0.0009/25/2024C$9.61C$9.61C$9.61C$9.55351 shsC$0.0009/24/2024C$9.28C$9.61+3.56%C$9.61C$9.55351 shsC$0.0009/12/2024C$9.28C$9.28C$9.28C$9.2810 shsC$0.0009/11/2024C$9.28C$9.28C$9.28C$8.912,300 shsC$0.0009/10/2024C$8.91C$9.28+4.15%C$9.28C$8.912,300 shsC$0.0009/09/2024C$9.87C$8.91-9.73%C$8.91C$8.91100 shsC$0.0009/06/2024C$9.87C$9.87C$9.87C$9.87200 shsC$0.0009/05/2024C$9.96C$9.87-0.90%C$9.87C$9.87200 shsC$0.0009/04/2024C$9.96C$9.96C$9.96C$9.96400 shsC$0.0009/03/2024C$10.20C$9.96-2.35%C$9.96C$9.96400 shsC$0.0008/29/2024C$10.20C$10.20C$10.20C$10.20300 shsC$0.0008/28/2024C$10.00C$10.20+2.00%C$10.20C$10.20300 shsC$0.0008/27/2024C$9.28C$10.00+7.78%C$10.00C$10.00325 shsC$0.0008/26/2024C$9.28C$9.28C$9.28C$9.283,000 shsC$0.0008/23/2024C$9.28C$9.28C$9.28C$9.283,000 shsC$0.0008/22/2024C$9.12C$9.28+1.73%C$9.28C$9.283,000 shsC$0.0008/21/2024C$9.12C$9.12C$12.75C$9.101,550 shsC$0.0008/20/2024C$10.40C$9.12-12.31%C$12.75C$9.101,550 shsC$0.0008/19/2024C$11.00C$10.40-5.45%C$10.40C$10.40225 shsC$0.00 Related Companies 180 Life Sciences Stock Chart 3SBio Stock Chart 60 Degrees Pharmaceuticals Stock Chart Abcam Stock Chart Agentix Stock Chart Algernon Pharmaceuticals Stock Chart ALK-Abelló A/S Stock Chart Alpha Tau Medical Stock Chart Anew Medical Stock Chart Apollomics Stock Chart Receive NURPF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neuren Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:NURPF) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredThis Hidden Threat Could Destroy Your RetirementEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredAI Stocks Are Poised to Explode Under TrumpDonald Trump's return to the White House has set the stage for an unprecedented market opportunity. His pro-bu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuren Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuren Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NURPF Stock Alerts